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rhythm management device between 2005 and 2011. This
analysis is based on the 5580 (65%) that were implanted
with an IPG, of which 782 patients were enrolled from
the ME (Kuwait n = 361 and Saudi Arabia n = 421).
Results: Compared to the other regions patients
from the ME were more likely to present with diabetes
(20% vs 37%, p < 0.001) and less likely to have NYHA
class II, III or IV (34% vs 7%, p < 0.001) or atrial fibrillation
(33% vs 17%, p < 0.001). The ME region had the highest
proportion of patients implanted with a single chamber
device and AV block indication.
Conclusion: The Panorama IPG cohort provides a
unique opportunity to examine the implant practices
and clinical profiles of patients implanted with an IPG
in the Middle East region. We found significant differ-
ences in patient characteristics, type of IPG, and choice
of programming. Further work is needed to understand
how these differences might contribute to differences in
patient management and outcomes.
http://dx.doi:10.1016/j.jsha.2013.03.153
Assessment of the hemodynamic changes follow-
ing fluid preloading in cardiac surgery
Raed Amrullah Alsatli
Department of Anesthesiologist, College of Medicine,
King Fahad Cardiac Center, King Saud University,
Riyadh, Saudi Arabia; Department of Cardiac Science,
P.O. Box: 7805 (Internal 92), College of Medicine, King
Saud University, Riyadh 11472, Saudi Arabia
Background: This prospective double-blind ran-
domized study aims to study the hemodynamic changes
following fluid preloading with Hydroxyethyl starch
(HES) 6% (130/0.4) compared with normal saline (NS)
in cardiac surgery patients.
Methods: Forty patients undergoing coronary artery
bypass grafting (CABG) were enrolled in this study, then
they were divided in 2 equal groups, HES and NS. After
fast administration of 10 mL/kg from either solutions
over 5 min only, hemodynamic parameters, such as heart
rate, mean arterial pressure (MAP), central venous pres-
sure (CVP), pulmonary artery occlusion pressure
(PAOP), mean pulmonary artery pressure, systemic vas-
cular resistance, and pulmonary vascular resistance were
measured every 5 min for the total duration of 40 min.
Results: There were significant differences in the cardiac
index measurements between both groups at 15 min
onward; also PAOP was significantly higher in HES
group at 10 min onward. CVP was higher in HES group
but statistically significant at 10 min only. MAP was
higher in HES group, but that was statistically significant
at 40 min only. On the other hand PAP was significantly
higher at 10 and 40 min.
Conclusion: Fluid preloading with HES led to a sig-
nificant increase in filling pressure of the left ventricle
(PAOP) and cardiac index compared with NS. We believe
that HES (130/0.4) could be a suitable solution for fluid
preloading in CABG surgery patients. However, further
studies are needed on different fluid preloading modali-
ties with different dosing regimens.
http://dx.doi:10.1016/j.jsha.2013.03.154
Impact of atrioventricular compliance on clinical
outcome of patients undergoing successful percu-
taneous balloon mitral valvuloplasty
Ragab Abdelsalam Mahfouz, Waled Elawady,
Ekhlas Hossein, Ahmad Yosri
Objective: We aimed to assess the impact of atrio-
ventricular compliance (Cn) on the clinical outcome, pul-
monary hypertension (PH) and right ventricular (RV)
function changes after successful percutaneous balloon
mitral valvuloplasty (PBMV).
Methods and results: Using Doppler echocardiogra-
phy Cn was estimated from the equation that has been
previously validated. Mitral valve area, tricuspid annular
plane systolic excursion (TAPSE), pulmonary artery pres-
sure (PAP) and degree of TR severity were evaluated
before, immediately and every 6 months with a median
duration of 32 months after successful PBMV in 150 con-
secutive patients. Compared to control subjects patients
with MS had significant lower Cn (P < 0.0001). An imme-
diate drop in PAP and significant improvement of RV
function was observed after PBMV. Cn was correlated
with the degree of PAPs, TAPSE (P < 0.0001). Patients
with Cn < 3.75 mL/mmHg had higher incidence of
adverse outcome (developing atrial fibrillation, worsen-
ing RV function, progressive left atrial dilation and redo
intervention). Multivariate regression analysis showed
that the Cn was the strongest independent predictor of
PAPs and RV functional before and after successful
PBMV (P < 0.0001). Cn < 3.75 mL/mmHg was the cut-of
value for prediction of clinical events at follow-up.
Conclusions: The change and follow-up in RV func-
tion and pulmonary hypertension after successful PBMV
were significantly correlated with the degree of Cn. This
suggests a significant role of Cn in patients with MS, pro-
viding a good insight for intervention and utilizing Cn as
a non-invasive hemodynamic index for risk stratification
and proper timing for intervention in patients with MS.
http://dx.doi:10.1016/j.jsha.2013.03.155
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Objectives: This prospective study designed to
assess the safety and short and intermediate term effi-
cacy of drug-eluting balloon (DEB) in the treatment of
de-novo, in-stent restenotis and bifurcation coronary
artery disease (CAD) in Saudi Arabic Population.
Methods: Total of 64 patients so far enrolled in a pro-
spective registry using a Be Brown Paclitaxel-coated bal-
loon (DEB) at our hospital, 61 patients were studied for
short and intermediate term outcomes (6 to 12 months).
All patients with symptomatic CAD including 21 patients
33% of de-novo lesions, 25 patients 39% of in-stent reste-
nosis (ISR) and 17 patients 28% of bifurcation lesions
requiring percutaneous intervention (PCI) with a DEB
were included. Clinical follow-up was conducted at 6
and 12 months. Coronary angiography (CAG) or SPECT
Scan were done in 71% of patients during this period. Pri-
mary outcome was a composite of target vessel revascu-
larization and mortality.
Results: Procedural success was achieved in 96% of
the patients. Two patients were failed due to failed DEB
to cross heavily calcified vessel. Mean age was
60.8 ± 30 years. 47 patients 77% presented with Stable
angina and 9 patients 15% with acute coronary syndrome
(ACS). Twenty five patients 41% had triple vessel CAD.
Sixty percent were classified as having ACC/AHA B-2
or C type coronary arteries including 26% patients with
bifurcation lesions. Lesions stenting post DEB required
in 8 patients 13% due to either dissection (4 patients) or
inadequate result (4 patients). Mean DEB diameter was
2.2 ± 0.5 mm (2 to 3.5 mm)and mean length was
19.3 ± 8 mm (10 to 30 mm). Immediate result mean diam-
eter stenosis was 80% ± 8 decrease to 5% ± 9 post DEB
dilatation and the diameter stenosis reached 15% ± 20
with coronary angiography follow up at 6 to 12 months.
A 7 patients 11% has restenosis (6 patients from ISR
group and one patients from bifurcation lesions group)
the 7 patients required revascularization (5 patients has
PCI and 2 patients has CABG). A 37 patients 59% who
were followed by either recath (17 patients) or SPECT
Scan (20 patients) showed no evidence of restenosis.
The remained 17 patients 30% were followed clinically
and showed no Angina. One patient died from cancer
one month after PCI. There was no cerebrovascular acci-
dent and no major bleeding.
Conclusion: Be Brown Paclitaxel-coated balloon
(DEB) can be used safely with good and successful inter-
mediate result with target vessel restenosis of 7 patients
11.3% (5 patients has PCI and 2 patients has CABG)
and non cardiac mortality of 1.6%.
http://dx.doi:10.1016/j.jsha.2013.03.157
Influence of physical activity level on Saudi refer-
ence values of 6 min walk test
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Background: The 6 min walk test (6-MWT) is widely
used to evaluate exercise capacity in several cardiopul-
monary diseases due to its simplicity, applicability and
low cost. Establishing reference value is essential to
guide the diagnostic and prognostic use of the 6-MWT
and previous study showed that the Saudi subject’s age
and height were the most significant predictors for
6 min walked distance (6-MWD). On the other hand,
physical activity level proved to have direct effect on
the exercise capacity. This study aimed to answer the
question: Does the physical activity level influence the
Saudi reference values of 6-MWT?
Method: The main outcome measure was the 6 min
walked distance (6-MWD) which was measured by the 6-
MWT following the protocol of the American Thoracic
Association. The demographic characters, including age,
gender, weight, and height, of the participants were col-
lectedand their bodymass index (BMI)was calculated.Par-
ticipant’s physical activity level was calculated using the
Last 7 days International Physical Activity Questionnaire
(IPAQ) and was expressed as high, moderate and low lev-
els. For each participant the following cardiovascular vari-
ables were measured before and after the test; the heart
rate, systolic and diastolic blood pressure, and arterial oxy-
gen saturation. The percent from the predicted maximum
heart rate (%PMHR) was calculated for each participant.
The predictive power of the studied demographic and car-
diovascular characters to estimate the 6-MWD was evalu-
ated using the statistical program SPSS version 17.
Results: Participants in the current study are 359
Saudi health subjects (70.5% female). They aged from
18 to 71 years (31.0 ± 14.0 years). Results showed a signif-
icant (P = 0.0001) decrease in 6-MWD with increasing the
age. In addition, within the different age groups, male
participants showed longer 6-MWD than females (503.3
and 471.1 m respectively). This longer male’s 6-MWD
was significant in the younger age groups. From the
age of 50 years up to 71 years there was no significant
gender difference in the 6-MWD.
In all age groups, there were significant increase in 6-
MWD from low, moderate, to high physical activity level.
Moreover, the interaction between age, gender, and level
of physical activity was significant (P = 0.0001). Younger
male with high level of activity had the best 6-MWD.
Older age, female gender, and lower physical activity
level was accompanied with significant shorter 6-MWD.
The 6-MWD was positively correlated to the subject’s
height, heart rate, arterial oxygen saturation, and physi-
cal activity level. It was negatively correlated to age,
weight, BMI, % PMHR, systolic and diastolic blood
pressure.
Out of all these correlations within the studied demo-
graphic and cardiovascular factors; physical activity level,
age and gender were working as a predictive factors for
6-MWD of Saudi healthy subjects and were significantly
included in the regression equation to estimate the
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